The Multiple Mechanisms That Regulate P53 Activity and Cell Fate

Overview

Journal Nat Rev Mol Cell Biol

Specialties Cell Biology
Molecular Biology

Date 2019 Mar 3

PMID 30824861

Citations 480

Authors

Antonina Hafner

Martha L Bulyk

Ashwini Jambhekar

Galit Lahav

Affiliations

Soon will be listed here.

Abstract

The tumour suppressor p53 has a central role in the response to cellular stress. Activated p53 transcriptionally regulates hundreds of genes that are involved in multiple biological processes, including in DNA damage repair, cell cycle arrest, apoptosis and senescence. In the context of DNA damage, p53 is thought to be a decision-making transcription factor that selectively activates genes as part of specific gene expression programmes to determine cellular outcomes. In this Review, we discuss the multiple molecular mechanisms of p53 regulation and how they modulate the induction of apoptosis or cell cycle arrest following DNA damage. Specifically, we discuss how the interaction of p53 with DNA and chromatin affects gene expression, and how p53 post-translational modifications, its temporal expression dynamics and its interactions with chromatin regulators and transcription factors influence cell fate. These multiple layers of regulation enable p53 to execute cellular responses that are appropriate for specific cellular states and environmental conditions.

Citing Articles

Sex Disparities in P53 Regulation and Functions: Novel Insights for Personalized Cancer Therapies.

Cardano M, Buscemi G, Zannini L Cells. 2025; 14(5).

PMID: 40072091 PMC: 11898824. DOI: 10.3390/cells14050363.

Integrated spatial multi-omics profiling of Fusobacterium nucleatum in breast cancer unveils its role in tumour microenvironment modulation and cancer progression.

Zhao F, An R, Ma Y, Yu S, Gao Y, Wang Y Clin Transl Med. 2025; 15(3):e70273.

PMID: 40070022 PMC: 11897063. DOI: 10.1002/ctm2.70273.

The Role of p53 Mutations in Early and Late Response to Mitotic Aberrations.

Hertel A, Storchova Z Biomolecules. 2025; 15(2).

PMID: 40001547 PMC: 11852650. DOI: 10.3390/biom15020244.

Microbiota governs host chenodeoxycholic acid glucuronidation to ameliorate bile acid disorder induced diarrhea.

Lin Z, Feng Y, Wang J, Men Z, Ma X Microbiome. 2025; 13(1):36.

PMID: 39905483 PMC: 11792533. DOI: 10.1186/s40168-024-02011-8.

PTOV1 exerts pro-oncogenic role in colorectal cancer by modulating SQSTM1-mediated autophagic degradation of p53.

Fan Y, Li Y, Luo X, Xiang S, Hu J, Zhan J J Transl Med. 2025; 23(1):157.

PMID: 39905441 PMC: 11796032. DOI: 10.1186/s12967-025-06179-x.

References

Lane D, CRAWFORD L . T antigen is bound to a host protein in SV40-transformed cells. Nature. 1979; 278(5701):261-3. DOI: 10.1038/278261a0. View

Linzer D, Levine A . Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell. 1979; 17(1):43-52. DOI: 10.1016/0092-8674(79)90293-9. View

Baker S, Fearon E, Nigro J, Hamilton S, Preisinger A, Jessup J . Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science. 1989; 244(4901):217-21. DOI: 10.1126/science.2649981. View

Hollstein M, Sidransky D, Vogelstein B, Harris C . p53 mutations in human cancers. Science. 1991; 253(5015):49-53. DOI: 10.1126/science.1905840. View

Kandoth C, McLellan M, Vandin F, Ye K, Niu B, Lu C . Mutational landscape and significance across 12 major cancer types. Nature. 2013; 502(7471):333-339. PMC: 3927368. DOI: 10.1038/nature12634. View

Lawrence M, Stojanov P, Mermel C, Robinson J, Garraway L, Golub T . Discovery and saturation analysis of cancer genes across 21 tumour types. Nature. 2014; 505(7484):495-501. PMC: 4048962. DOI: 10.1038/nature12912. View

Dolgin E . The most popular genes in the human genome. Nature. 2017; 551(7681):427-431. DOI: 10.1038/d41586-017-07291-9. View

Hager K, Gu W . Understanding the non-canonical pathways involved in p53-mediated tumor suppression. Carcinogenesis. 2014; 35(4):740-6. PMC: 3977149. DOI: 10.1093/carcin/bgt487. View

Hu X, Chandler J, Park S, Liu K, Fernandes J, Orr M . Low-dose cadmium disrupts mitochondrial citric acid cycle and lipid metabolism in mouse lung. Free Radic Biol Med. 2018; 131:209-217. PMC: 6331287. DOI: 10.1016/j.freeradbiomed.2018.12.005. View

10.

Kruiswijk F, Labuschagne C, Vousden K . p53 in survival, death and metabolic health: a lifeguard with a licence to kill. Nat Rev Mol Cell Biol. 2015; 16(7):393-405. DOI: 10.1038/nrm4007. View

11.

Haupt Y, Maya R, Kazaz A, Oren M . Mdm2 promotes the rapid degradation of p53. Nature. 1997; 387(6630):296-9. DOI: 10.1038/387296a0. View

12.

Honda R, Tanaka H, Yasuda H . Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 1998; 420(1):25-7. DOI: 10.1016/s0014-5793(97)01480-4. View

13.

Kubbutat M, Jones S, Vousden K . Regulation of p53 stability by Mdm2. Nature. 1997; 387(6630):299-303. DOI: 10.1038/387299a0. View

14.

Shieh S, Ikeda M, Taya Y, Prives C . DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell. 1997; 91(3):325-34. DOI: 10.1016/s0092-8674(00)80416-x. View

15.

Barak Y, Juven T, Haffner R, Oren M . mdm2 expression is induced by wild type p53 activity. EMBO J. 1993; 12(2):461-8. PMC: 413229. DOI: 10.1002/j.1460-2075.1993.tb05678.x. View

16.

Aylon Y, Oren M . The Paradox of p53: What, How, and Why?. Cold Spring Harb Perspect Med. 2016; 6(10). PMC: 5046691. DOI: 10.1101/cshperspect.a026328. View

17.

Kannan K, Kaminski N, Rechavi G, Amariglio N, Givol D . DNA microarray analysis of genes involved in p53 mediated apoptosis: activation of Apaf-1. Oncogene. 2001; 20(26):3449-55. DOI: 10.1038/sj.onc.1204446. View

18.

Madden S, Galella E, Zhu J, Bertelsen A, Beaudry G . SAGE transcript profiles for p53-dependent growth regulation. Oncogene. 1997; 15(9):1079-85. DOI: 10.1038/sj.onc.1201091. View

19.

Mirza A, Wu Q, Wang L, McClanahan T, Bishop W, Gheyas F . Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression. Oncogene. 2003; 22(23):3645-54. DOI: 10.1038/sj.onc.1206477. View

20.

Kaeser M, Iggo R . Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo. Proc Natl Acad Sci U S A. 2002; 99(1):95-100. PMC: 117520. DOI: 10.1073/pnas.012283399. View